About EEP
Investment Orientation
The Team

EEP Portfolio




Investor Reporting
Contact Us
Site Map
Terms & Conditions


EEP Portfolio & Previous Investments: Azanta

Azanta A/S (“Azanta”) is a Danish specialty pharma company primarily operating within oncology, women´s health and addiction medicine.

The Company has it’s own sale force in the Nordic Countries and works with license and distribution partners in the rest of the world.   

Azanta seeks to be an international market leader within certain specialty pharma product categories,  employing innovative repositioning and drug formulation strategies.

Azanta currently markets (and make available under special authorisation) a portfolio of specialty pharmaceutical products, including Nimoral™, a hypoxic radio-sensitizer for the treatment of head and neck cancer patients undergoing primary radiotherapy,  and Angusta® for labour induction.



EEP Advisers Limited is Authorised and Regulated by the Financial Conduct Authority